AMPLIFICATION OF STAT3 AND TP53 MAY CONFER POOR PROGNOSIS IN PERIPHERAL T-CELL LYMPHOMA: ANALYSIS OF A SINGLE-CENTER COHORT

EHA Library, Alessandro Putelli, 4206937

FINAL RESULTS OF A PHASE II STUDY OF THE ANTI-PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) ANTIBODY ATEZOLIZUMAB IN RELAPSED/REFRACTORY EXTRANODAL NK/T-CELL LYMPHOMA: THE NCCH1903/ATTACK STUDY

EHA Library, Shinichi Makita, 4206938

PROPOSED DEFINITION FOR ‘PRIMARY REFRACTORY’ DISEASE IN NODAL PERIPHERAL T-CELL LYMPHOMA: AN AUSTRALASIAN-CANADIAN COLLABORATIVE STUDY

EHA Library, John Kuruvilla, 4206939

BRENTUXIMAB VEDOTIN PLUS CHP-LIKE VERSUS CHOEP REGIMEN FOR THE FIRST-LINE TREATMENT OF PTCL PATIENTS: A MULTI-CENTER PROPENSITY-MATCHED POPULATION-BASED STUDY

EHA Library, Jun Fang, 4206940

RARE GERMLINE VARIANTS SHAPE SUSCEPTIBILITY AND PROGNOSIS IN B-CELL LYMPHOMAS

EHA Library, Weicheng Ren, 4206941

EFFICACY AND SAFETY OF GOLIDOCITINIB-CONTAINING REGIMENS IN RELAPSED/REFRACTORY PERIPHERAL T CELL LYMPHOMA: A REAL WORLD STUDY

EHA Library, Liufang Gu, 4206942

REAL-WORLD OUTCOMES OF PERIPHERAL AND CUTANEOUS T-CELL LYMPHOMAS IN KAZAKHSTAN: A NATIONWIDE MULTICENTER STUDY

EHA Library, Ayazhan Umutbayeva, 4206943

INCIDENCE AND PREDICTORS OF CARDIOVASCULAR EVENTS AFTER ANTHRACYCLINE-CONTAINING CHEMOTHERAPY IN LYMPHOMA: A RETROSPECTIVE LONGITUDINAL COHORT

EHA Library, Dewan Zhao, 4206944

SURVIVAL BENEFIT ASSOCIATED WITH TREATMENT AT ACADEMIC CANCER PROGRAMS IN OLDER ADULTS WITH PTCL: A NATIONAL CANCER DATABASE ANALYSIS

EHA Library, Henry Idrobo, 4206945

PHASE IB STUDY OF SHR0302 PLUS SHR2554 IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA: SAFETY RUN-IN AND INITIAL EFFICACY

EHA Library, Rong Tao, 4206946

TARGETING TNFR2 WITH BI-1808 WITH OR WITHOUT PEMBROLIZUMAB: IMMUNE ACTIVATION AND PROMISING RESPONSES IN ADVANCED CUTANEOUS T-CELL LYMPHOMAS

EHA Library, Stefan Barta, 4206947

CHANGES IN LEAN MUSCLE MASS, MUSCLE STRENGTH, AND PHYSICAL PERFORMANCE FOLLOWING FIRST‐LINE CHEMOTHERAPY IN PATIENTS WITH MALIGNANT LYMPHOMA

EHA Library, Charlotte Grønset, 4206948

MENDELIAN RANDOMIZATION REVEALS THE CAUSATIVE ROLE OF GENETICALLY PREDICTED VIRAL INFECTION IN PAN-LYMPHOMA RISK

EHA Library, Haiwen Huang, 4206949

TOTAL METABOLIC TUMOR VOLUME AND CIRCULATING TUMOR DNA AS EARLY PROGNOSTIC FACTORS IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM THE PHASE 3 STARGLO TRIAL

EHA Library, William Townsend, 4206950

SPATIAL TRANSCRIPTOMICS REVEALS STEPWISE FORMATION OF DISTINCT CUTANEOUS NICHES IN NODAL T FOLLICULAR HELPER CELL LYMPHOMA

EHA Library, Yuri Tsuboi, 4206951

EARLY OUTCOME PREDICTION OF DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS USING ON-TREATMENT OMICS DATA

EHA Library, Tom van den Bosch, 4206952

PLASMA PROTEOMIC SIGNATURES DISTINGUISH LYMPHOMA FROM OTHER CANCERS AND NON-MALIGNANT CONDITIONS IN PATIENTS PRESENTING WITH NON-SPECIFIC SYMPTOMS

EHA Library, Fredrika Wannberg, 4206953

SPATIAL PROFILING OF T CELL SUBSETS REVEALS DISTINCT IMMUNE MICROENVIRONMENT PATTERNS ASSOCIATED WITH SURVIVAL IN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Filippa Wikström, 4206955

GENOMIC AND TRANSCRIPTOMIC LANDSCAPE OF FOLLICULAR LYMPHOMA

EHA Library, Matin Salehi, 4206956

INTEGRATION OF END-OF-TREATMENT CIRCULATING TUMOR DNA WITH PET-CT IMPROVES RESPONSE ASSESSMENT IN CLASSICAL HODGKIN LYMPHOMA

EHA Library, Vincent Camus, 4206957

REDUCED CD20 EXPRESSION AND INTRATUMORAL CD3+ T CELLS FOLLOWING EPCORITAMAB TREATMENT ARE ASSOCIATED WITH PROGRESSIVE DISEASE IN A SUBSET OF DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA

EHA Library, Monica Wielgos-Bonvallet, 4206958

OUTCOMES BY LYMPHOMAP ARCHETYPES IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA FROM THE POLARIX TRIAL

EHA Library, R. Andrew Harkins, 4206959

CHROMOSOME 8Q COPY NUMBER GAIN PREDICTS EARLY RELAPSE IN HIGH-GRADE DIFFUSE LARGE B-CELL LYMPHOMA WITH MYC AND BCL2 REARRANGEMENTS

EHA Library, Tom van den Bosch, 4206960

BRIGATINIB RESISTANCE IN PEDIATRIC ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA IS DRIVEN BY GPX4-MEDIATED FERROPTOSIS SUPPRESSION

EHA Library, Gerardo Enrique Abarca Ríos, 4206961

THE STRESS-SENSING MARCH5 AXIS GOVERNS BLOOD CANCER APOPTOTIC RESILIENCE VIA TRACTABLE PROTEIN–PROTEIN INTERACTIONS

EHA Library, Thomas Lew, 4206962

GENOMIC ARCHITECTURE OF IRF4 REARRANGEMENTS IN CHILDREN AND ADULT LARGE B-CELL LYMPHOMAS

EHA Library, Ariadna Colmenero, 4206963

PHASE 3 INMIND TRIAL OF TAFASITAMAB (TAFA) PLUS LENALIDOMIDE (LEN) AND RITUXIMAB (R) IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): ANALYSES OF BIOMARKERS PREDICTIVE OF PATIENT (PT) RESPONSE

EHA Library, Diana Alvarez Arias, 4206964

INTEGRATED SNV/CNV PROFILING AT DIAGNOSIS IN MANTLE CELL LYMPHOMA IDENTIFIES GENOMIC CORRELATES OF CLINICAL HETEROGENEITY AND OUTCOME

EHA Library, Jana Karolová, 4206965

RHOA IS ESSENTIAL FOR NPM-ALK-DRIVEN LYMPHOMAGENESIS AND REPRESENTS A PROMISING THERAPEUTIC TARGET IN ALK+ ALCL

EHA Library, Claudia Voena, 4206966

PD-L1 AMPLIFICATION BUILDS AN IMMUNE FORTRESS IN EBV+ DLBCL: SPATIAL MULTI-OMICS REVEALS PHYSICAL T-CELL EXCLUSION ALONGSIDE FUNCTIONAL SUPPRESSION

EHA Library, Axel Künstner, 4206967

ASSOCIATION OF GERMLINE IEI GENE MUTATIONS WITH DISEASE SUBTYPES AND PROGNOSIS IN PEDIATRIC LYMPHOMA

EHA Library, Keyan Yang, 4206968

GENETIC ALTERATIONS IN PEDIATRIC B-CELL NON-HODGKIN LYMPHOMA IN PATIENTS WITH INBORN ERRORS OF IMMUNITY

EHA Library, Sara Mato, 4206969

PHARMACODYNAMIC BIOMARKERS SUPPORT THE CLINICAL BENEFIT OF EPCORITAMAB PLUS RITUXIMAB AND LENALIDOMIDE (R2) IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): ANALYSES FROM EPCORE FL-1

EHA Library, Lorenzo Falchi, 4206970

LONGITUDINAL SINGLE-CELL ANALYSIS REVEALS CLONAL EVOLUTION AND THERAPEUTIC RESISTANCE IN LYMPHOMA ASSOCIATED WITH INBORN ERROR OF IMMUNITY

EHA Library, Hui Wan, 4206971

SINGLE-CELL RNA SEQUENCING REVEALS THE TUMOR MICROENVIRONMENT AND MOLECULAR FEATURES OF MALIGNANT T CELLS IN ADVANCED CUTANEOUS T-CELL LYMPHOMA

EHA Library, Jieting Wang, 4206972

RELAPSE IN PEDIATRIC ALK⁺ ALCL IS ASSOCIATED WITH EARLY INFLAMMATORY SIGNALING AND TUMOR MICROENVIRONMENT REMODELING

EHA Library, Rebekka Salzmann, 4206973

PATIENT-DERIVED LYMPHOMA SPHEROIDS AS PRECLINICAL MODELS FOR PREDICTING PATIENT RESPONSES TO ADVANCED THERAPIES IN B-NHL: EXAMPLE OF GLOFITAMAB IN FOLLICULAR LYMPHOMA

EHA Library, christine Bezombes, 4206974

CK2 INHIBITION REPROGRAMS THE EPIGENETIC LANDSCAPE AND ENHANCES SENSITIVITY TO TARGETED THERAPY IN GERMINAL CENTER DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Amir Yami, 4206975

INTEGRATIVE MULTI-OMICS FRAMEWORK IDENTIFIES TGFB1–CXCL12 SIGNALING AS A CONSERVED IMMUNOREGULATORY NETWORK IN HIGH-GRADE B-CELL LYMPHOMA AND REACTIVE LYMPHOID TISSUES

EHA Library, Keisuke Kidoguchi, 4206976

PERIPHERAL PROTEOMIC SIGNATURES ASSOCIATED WITH CYTOKINE RELEASE SYNDROME (CRS) IN PATIENTS (PTS) WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AND FOLLICULAR LYMPHOMA (FL) TREATED WITH ODRONEXTAMAB

EHA Library, Stefano Luminari, 4206977

PRETREATMENT CTDNA-BASED RISK PREDICTION IN DLBCL: PANEL-INDEPENDENT COPY-NUMBER ANALYSIS OVERCOMES INTER-ASSAY THRESHOLD VARIABILITY

EHA Library, Rebecca Goodhew, 4206978

AID INACTIVATION PROMOTES APOBEC-MEDIATED MUTAGENESIS IN GERMINAL CENTER LYMPHOMA

EHA Library, Sandrine Sander, 4206979

RITUXIMAB-MODIFIED MNO₂-COATED ZIF-8 NANOPLATFORM LOADED WITH DOXORUBICIN FOR TARGETED THERAPY OF B-CELL LYMPHOMA

EHA Library, Hao Yao, 4206980

TARGETING HELLS-MCM5 AXIS TO EXPLOIT TRANSCRIPTION-REPLICATION CONFLICTS AS NOVEL THERAPEUTIC STRATEGY IN ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, Valentina Fragliasso, 4206983

DIOSCIN INHIBITS DIFFUSE LARGE B-CELL LYMPHOMA BY MODULATING ACACA-DEPENDENT HISTONE H3K27 ACETYLATION AND INDUCING MITOPHAGY

EHA Library, Qianqian Guo, 4206984

INTEGRATED MOLECULAR AND METABOLIC PROFILING IDENTIFIES DETERMINANTS OF OUTCOME WITH LONCASTUXIMAB TESIRINE IN RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Ciro Maria Improta, 4206985

DURABLE RESPONSES WITH RONDECABTAGENE AUTOLEUCEL (DUAL-TARGETING CD19/CD20 CAR T-CELLS) ARE ASSOCIATED WITH HIGHER PROPORTION OF CYTOTOXIC T CELLS WITH MEMORY POTENTIAL IN INFUSION PRODUCTS

EHA Library, Akil Merchant, 4206986

TAXONOMIC AND FUNCTIONAL INTESTINAL MICROBIOME PROFILES DISTINGUISH MANTLE CELL LYMPHOMA PATIENTS FROM CONTROLS AND PERSIST ACROSS DISEASE STATES

EHA Library, Justin Desroches, 4206987

INTEGRATIVE TRANSCRIPTOMIC PROFILING REVEAL THE MOLECULAR LANDSCAPE AND REGULATORY DRIVERS OF BLASTOID MANTLE CELL LYMPHOMA

EHA Library, Li Wang, 4206988

CLINICAL AND MOLECULAR CHARACTERISTICS AND THEIR IMPACT ON PROGNOSIS IN CHINESE PEDIATRIC MATURE B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Qinlong Zheng, 4206989

WHOLE-GENOME SEQUENCING REVEALS DISTINCT MOLECULAR CLASSIFICATION PATTERNS IN DIFFUSE LARGE B-CELL LYMPHOMA IN CHINESE PATIENTS

EHA Library, Mingyu Yang, 4206990

THE NEUROENDOCRINE-METABOLIC-IMMUNE AXIS IN B-CELL LYMPHOMA: ROLE OF ACBP/DBI IN GLUCOCORTICOID RESISTANCE AND IMMUNOSUPPRESSION

EHA Library, Hui PAN, 4206991

CLONAL COMPLEXITY DEFINES DISTINCT TUMOR-INTRINSIC BIOLOGY AND PROGNOSIS IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Takahiro Haeno, 4206993

TARGETING RNF20 INHIBITS THE PROGRESSION OF DIFFUSE LARGE B-CELL LYMPHOMA THROUGH REGULATING UBIQUITINATION-DEPENDENT PHASE SEPARATION OF FUS

EHA Library, Qianqian Guo, 4206994

PHASED VARIANTS REVEAL PROTO-ONCOGENE PROMOTER HYPERMUTATION AND CFDNA FRAGMENTATION PATTERNS IN DLBCL

EHA Library, Luca Varga, 4206995

PROTEOLYSIS-TARGETING CHIMERA (PROTAC) TARGETING BRUTON TYROSINE KINASE (BTK) DEGRADATION IN MANTLE CELL LYMPHOMA

EHA Library, Xiaohui Wang, 4206996

ALLOGENEIC TRANSPLANTATION: DISEASE RESPONSE AND COMPARATIVE TREATMENT STUDIES

EHA Library, xiaodong lyu, 4206997

ALLOGENEIC HSC TRANSPLANTATION INCREASES ACETYLCHOLINE PRODUCTION BY DONOR-DERIVED LYMPHOCYTES, WHICH RESTRAINS T CELL ACTIVATION AND EXPANSION VIA ALPHA7 NICOTINIC RECEPTOR - IMPLICATIONS FOR GVHD

EHA Library, Jose Antonio Bejarano Garcia, 4206998

CLONAL DYNAMICS OF THE TCRΒ REPERTOIRE REVEAL PREDICTIVE IMMUNE SIGNATURES OF POST-TRANSPLANT COMPLICATIONS

EHA Library, xiaodong lyu, 4206999

CIRCULATING MICRORNA SEQUENCING REVEALS CONSISTENT EXPRESSION DYNAMICS ACROSS MOBILIZATION STRATEGIES AND PREDICTIVE MARKERS OF EFFICACY IN MULTIPLE MYELOMA PATIENTS

EHA Library, Damian Mikulski, 4207000

EPIGENETIC MODULATION ENABLES EXPANSION OF FUNCTIONAL HUMAN HSPCS IN A CHEMICALLY DEFINED SYSTEM FOR CELL AND GENE CLINICAL APPLICATIONS

EHA Library, Nobuchika Yamamoto, 4207001

EARLIER EMERGENCE OF PROLIFERATIVE CD8+ T CELLS IS ASSOCIATED WITH IMPROVED PROGNOSIS IN R/R DLBCL PATIENTS TREATED WITH AUTO-HSCT PLUS UMBILICAL CORD BLOOD INFUSION

EHA Library, Zhengchang He, 4207002

PROLIFERATING TCF1LOW PD-1HIGH POPULATION IN HUMAN CD8+ T-CELLS IS ASSOCIATED WITH THE ONSET OF AGVHD AND SUPPRESSED BY PTCY

EHA Library, Kazuya Asano, 4207003

IMPACT OF EARLY POST-TRANSPLANT MEASURABLE RESIDUAL DISEASE ON OUTCOMES OF PATIENTS WITH RELAPSED/ REFRACTORY AML: A POST-HOC ANALYSIS OF THE PROSPECTIVE ASAP TRIAL

EHA Library, Katharina Egger-Heidrich, 4207004

OUTCOME OF PATIENTS TREATED FOR T-ALL WITH HSCT IN THE FORUM COHORT

EHA Library, Jeanne Martin, 4207005

ROMIPLOSTIM N01 FOR PLATELET RECOVERY AFTER UNRELATED UMBILICAL CORD BLOOD TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: A PHASE II, SINGLE-ARM STUDY

EHA Library, Wanjie Wang, 4207006

IMPACT OF DONOR AGE ON OUTCOMES OF ALTERNATIVE DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC SEVERE APLASTIC ANEMIA

EHA Library, Jingyu Gao, 4207007

PHASE II STUDY OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH AUTOLOGOUS CD19-CAR T CELL INFUSION IN ADULTS WITH HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CLINICAL OUTCOMES

EHA Library, Rongli Zhang, 4207008

LONG-TERM EFFICACY AND SAFETY OF DONOR-DERIVED CAR-T CELLS INTEGRATED INTO ALLOGENEIC HSCT CONDITIONING FOR ULTRA-HIGH-RISK R/R B-NHL, T-LBL, AND MULTIPLE MYELOMA: A 5-YEAR FOLLOW-UP STUDY

EHA Library, Fan Yang, 4207009

SUPERIOR OUTCOMES WITH B-LEADER-MATCHED HAPLOIDENTICAL VERSUS MATCHED SIBLING DONORS IN AL/MDS PATIENTS AGED ≥40 YEARS

EHA Library, Yujun Wei, 4207010

INTEGRATING IMS–IMWG GENOMIC RISK WITH R2-ISS IMPROVES RISK STRATIFICATION IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA

EHA Library, Oren Pasvolsky, 4207011

GENETIC ABNORMALITIES INFLUENCE THE PROGNOSTIC VALUE OF PRE-TRANSPLANT MEASURABLE RESIDUAL DISEASE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA: A MULTICENTRE STUDY

EHA Library, Yue Jin, 4207012

THE SAFETY AND EFFICACY OF BELUMOSUDIL AND RUXOLITINIB COMBINATION IN RUXOLITINIB REFRACTORY CGVHD

EHA Library, Yibo Wu, 4207014

THIOTEPA-FLUDARABINE-TREOSULFAN VS THIOTEPA-FLUDARABINE-BUSULFAN IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ADULT AML PATIENTS IN CR. A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT.

EHA Library, Enrico Maffini, 4207015

HOSPITAL BASED OUTPATIENT DAILY DOSING MYELOABLATIVE INTRAVENOUS AND PHARMACOKINETICALLY GUIDED BUSULFAN BASED CONDITIONING FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT – SINGLE CENTER EXPERIENCE

EHA Library, Mathias Palmer, 4207016

RESPIRATORY TRACT INVASIVE FUNGAL INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE IN AML AND MDS: A  STUDY CONDUCTED ON BEHALF OF GETH-TC

EHA Library, Maria Queralt Salas, 4207017

RISK FACTORS AND PROGNOSTIC INDICATORS OF ACUTE RESPIRATORY FAILURE FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE COHORT STUDY

EHA Library, Xiaojin Wu, 4207018

CPX-351 BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION, A REAL-WOLRD FRENCH EXPERIENCE

EHA Library, Eléonore Kaphan, 4207019

IMMUNOSUPPRESSIVE STRATEGY USING LOW-DOSE ATG COMBINED WITH ANTI-CD25 ANTIBODY FOR GVHD PROPHYLAXIS IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiaosheng Fang, 4207020

IMPACT OF CONCURRENT GRAFT-VERSUS-HOST DISEASE ON LONG-TERM SURVIVAL IN CRITICALLY ILL PATIENTS FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES

EHA Library, Zhixue Li, 4207021

BURDEN, SPECTRUM, AND PROGNOSTIC IMPACT OF INFECTIONS AFTER ALLOHSCT IN PATIENTS ≥65 YEARS: A GETH-TC STUDY

EHA Library, Sara Fernandez-Luis, 4207022

ASSOCIATIONS OF AGE AND PRE-TRANSPLANT EMOTIONAL STATUS WITH EARLY IMMUNE RECONSTITUTION AFTER PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jiali Ma, 4207023

IMMUNE RECONSTITUTION AFTER HAPLO-IDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANT: A PROSPECTIVE REAL-WORLD STUDY

EHA Library, Himani Gupta, 4207024

ROMIPLOSTIM N01 FOR PROMOTING PLATELET ENGRAFTMENT AFTER ALLO-HSCT: INTERIM RESULTS OF A PHASE II EXPLORATORY TRIAL FROM NICHE COHORT

EHA Library, Shan Jiang, 4207025

THE COMBINATION OF RUXOLITINIB AND EXTRACORPOREAL PHOTOPHERESIS IS A HIGHLY EFFECTIVE SECOND LINE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE

EHA Library, Andrea Varkonyi, 4207026

EFFICACY OF LOW-DOSE ATG COMBINED WITH PTCY IN CHILDREN WITH CHRONIC GRANULOMATOUS DISEASE UNDERGOING HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yingjian Si, 4207027

MYELOABLATIVE FRACTIONATED BUSULFAN, FLUDARABINE, CLADRIBINE, THIOTEPA, AND VENETOCLAX (CLADILLAC) CONDITIONING FOR HIGH-RISK AML: A PHASE 2 TRIAL

EHA Library, Uday R. Popat, 4207028

EXPLORATION OF A NOVEL AGVHD PROPHYLAXIS REGIMEN BASED ON GECACITINIB IN THE PERITRANSPLANT PERIOD OF PATIENTS WITH MYELOFIBROSIS: A PILOT OPEN-LABEL STUDY

EHA Library, Na Xu, 4207029

LONGITUDINAL TCR SEQUENCING REVEALS DONOR-DEPENDENT IMMUNE RECONSTITUTION PATTERNS AFTER PEDIATRIC ALLOGENEIC HSCT FOR PRIMARY IMMUNODEFICIENCIES

EHA Library, Guanghua Zhu, 4207030

DONOR-DERIVED CYTOGENETIC ALTERATIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE SINGLE-CENTER COHORT STUDY

EHA Library, Corinne Widmer, 4207031

A MOLECULAR-BASED RISK SCORE FOR PREDICTING LEUKEMIA-FREE SURVIVAL IN ADULT AML PATIENTS UNDERGOING ALLO-HSCT

EHA Library, Shuang Li, 4207032

POST-TRANSPLANT ASCIMINIB TREATMENT AS MAINTENANCE, PRE-EMPTIVE OR RELAPSE THERAPY IN PHILADELPHIA-POSITIVE ADVANCED LEUKEMIAS: MULTICENTER REAL-WORLD DATA ANALYSIS

EHA Library, Mohamed Isam Sharif, 4207033

TREATED WITH EMAPALUMAB AS A BRIDGE TO HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY/RECURRENT EPSTEIN-BARR VIRUS-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Na Wei, 4207034

A PHASE II STUDY OF A BUSULFAN IN COMBINATION WITH FLAG CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETC STEM CELL TRANSPLANTATION

EHA Library, Xiawei Zhang, 4207035

ALLOGENEIC STEM CELL TRANSPLANTATION FOR SECONDARY HEMATOLOGIC MALIGNANCIES ARISING FROM PLASMA CELL NEOPLASM

EHA Library, Masaya Maegaki, 4207036

LONGITUDINAL ASSESSMENT OF COMPLEMENT FACTOR BA AND CLINICAL RESPONSE IN ADULT TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY

EHA Library, Min Wu, 4207037

TRANSPLANTATION STRATEGIES FOR LYMPHOMA ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-A MULTICENTER, REALWORLD STUDY

EHA Library, Jiexian Ma, 4207038

IMPACT OF RECIPIENT AGE ON OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: AN ANALYSIS FROM THE CHINESE BONE MARROW TRANSPLANT REGISTRY GROUP (CBMTRG)

EHA Library, Xiaoli Liang, 4207039

ASSESSMENTS OF BONE HEALTH AMONG PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE RECEIVING AXATILIMAB IN THE AGAVE-201 TRIAL

EHA Library, Amandeep Salhotra, 4207040

A PROSPECTIVE COHORT STUDY: THE ASSOCIATION BETWEEN NUTRITIONAL STATUS OF HSCT PATIENTS BEFORE TRANSPLANTATION AND EARLY INFECTION AND NON-RELAPSE MORTALITY

EHA Library, Weiwei Qin, 4207041